Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients
- Status
- RECRUITING
- Phase
- N/A
Allogeneic iNKT Cell Therapy (agenT-797) After SCT
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapsed/Refractory Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Plasma ctDNA Monitoring in Pediatric Acute Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Harnessing the Immunosuppressive Leukemic Microenvironment to Engineer T Cells With Enhanced Anti-tumor Functionality
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Geriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- NA
VA Consolidation in Intermediate-Risk AML
- Status
- RECRUITING
- Phase
- PHASE2
Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of CRD3874-SI in People With Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2/PHASE3
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition.
- Status
- RECRUITING
- Phase
- N/A